From:	Jackson, Andrea [andrea.jackson@lmco.com]
Sent:	Friday, July 23, 2010 11:11 AM
To:	Osei-Poku, William
Subject:	FW: EXTERNAL: Re: FW: Status Update- Protocol S0722

Hi William,

This is the trial that touched base about this morning on our call.

AJ

Andrea J. Jackson
Lockheed Martin Business Process  Services NCI's PDQ Cancer Clinical Trial 
Registry
301-594-9266 or 301-519-5967
pdqupdate@cancer.gov




-----Original Message-----
From: register@clinicaltrials.gov [mailto:register@clinicaltrials.gov]
Sent: Friday, July 23, 2010 11:09 AM
To: Jackson, Andrea
Subject: EXTERNAL: Re: FW: Status Update- Protocol S0722

done

Jackson, Andrea wrote:
>
> Can you please transfer the trial below back to NCI's PRS account.
>
>  
>
> SouthwestOG
>
> DSparks
>
> CDR0000616162
>
>  
>
> Thanks!
>
> Andrea
>
>  
>
> Andrea J. Jackson
>
> Lockheed Martin Business Process  Services
>
> NCI's PDQ Cancer Clinical Trial Registry
>
> 301-594-9266 or 301-519-5967
>
> pdqupdate@cancer.gov <mailto:pdqupdate@cancer.gov>
>
>  
>
> New Image
>
>  
>
> *From:* Sparks, Dana [mailto:DSparks@swog.org]
> *Sent:* Friday, July 23, 2010 8:57 AM
> *To:* Jackson, Andrea
> *Subject:* EXTERNAL: RE: Status Update- Protocol S0722
>
>  
>
> I'm fine with having it transferred back to NCI's account.  Do I need 
> to do anything in the clinicaltrials.gov system to accomplish this?
>
>  
>
> ----------------------------------------------------------------------
> --
>
> *From:* Jackson, Andrea [mailto:andrea.jackson@lmco.com]
> *Sent:* Friday, July 23, 2010 7:54 AM
> *To:* Sparks, Dana
> *Subject:* FW: Status Update- Protocol S0722
>
> Hi Dana,
>
>  
>
> It appears that S0722 was mistakenly transferred to SWOG's PRS account 
> in ClinicalTrials.gov.  In order to make the status update I need your 
> permission to have the trial transferred back to NCI's account.  I 
> hope this makes sense but please feel free to call me with any questions.
>
>  
>
> Thanks,
>
> Andrea
>
>  
>
> Andrea J. Jackson
>
> Lockheed Martin Business Process  Services
>
> NCI's PDQ Cancer Clinical Trial Registry
>
> 301-594-9266 or 301-519-5967
>
> pdqupdate@cancer.gov <mailto:pdqupdate@cancer.gov>
>
>  
>
> New Image
>
>  
>
>  
>
> *From:* Monahan, Meghan (NIH/NCI) [C]
> *Sent:* Wednesday, July 21, 2010 9:05 AM
> *To:* Dansky Ullmann, Claudio (NIH/NCI) [E]
> *Cc:* NCI PDQ Update; NCI Clinical Trials Reporting Office; Mahmood, 
> Faizan (NIH/NCI) [C]; NCI Doc Box; Sparks, Dana
> *Subject:* Status Update- Protocol S0722
>
>  
>
> Protocol S0722 "A Phase II Trial of mTOR Inhibitor, Everolimus 
> (RAD001), in Malignant Pleural Mesothelioma (MPM)"
>
> Reactivated on April 1, 2010.
>
>  
>
> *PDQ, Emmes and CTRO, please note that this status update should have 
> been distributed in April.  The trial is still listed as closed on 
> clinicaltrials.gov so any help in expediting the status update would 
> be greatly appreciated.  Thank you in advance for your attention to 
> this matter.*
>
>  
>
> Regards,
>
> Meghan
>
>  
>
> Meghan Monahan
>
> Senior Protocol Specialist
>
> Protocol and Information Office
>
> Contractor - Technical Resources International
>
> Operations and Informatics Branch
>
> National Cancer Institute
>
> National Institutes of Health
>
> Phone: 301-594-9672
>
> For all PIO submissions, please e-mail: pio@ctep.nci.nih.gov 
> <mailto:pio@ctep.nci.nih.gov>
>
>  
>